Caroline Elsner, Clinical Research Coordinator at Washington University School of Medicine in St. Louis, shared on LinkedIn:
“Big advancements in melanoma research!
I’m proud to be the Clinical Research Coordinator of this clinical trial investigating personalized mRNA-based therapies for patients with high-risk melanoma at Siteman Cancer Center at WashU Medicine.
Recent Phase III results demonstrate promising improvements in recurrence-free survival, marking an exciting step forward in personalized cancer treatment.
You might be interested in:
INMC Analysis: Can Pathological Response Guide Treatment in Melanoma?
